Exploring Strategies to Align Manufacturing of Stem Cell Derived Products to the Safety & Efficacy of the Product Whilst Meeting CMC Requirements
Time: 11:00 am
day: Conference Day 2
Details:
- Illustrating ways to generate high quality induced pluripotent stem cells (iPSCs)
- Understanding the specific differentiation into ventricular cardiomyocytes to minimize safety risks of the cells
- Establishing a scalable manufacturing system to purify cardiomyocytes and reduce the cost of goods
